Credit Suisse reported on Wednesday that it has raised its price target on health benefits company, Aetna Inc. (AET).
The firm, which currently has a “Neutral” rating on the AET, has increased the company’s price target to $65. This price target suggests 8% upside from the stock’s current price of $59.44.
Analysts have also raised estimates on the company through 2014 as the acquisition of Coventry Health is expected to improve earnings.
Aetna shares were mostly flat during Wednesday morning trading. The stock is up 28% YTD.
The Bottom Line
Shares of Aetna Inc. (AET) have a 1.34% yield, based on Wednesday’s closing price of $59.55.
Aetna Inc. (AET) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.